Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 13.95
+0.26 (1.90%)
Jul 24, 2026, 3:55 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 290.6 million as of July 24, 2026. Its market cap has increased by 194.33% in one year.
Market Cap
290.60M
Enterprise Value
193.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.95
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 290.60M, an increase of 393.95%. That is a compound annual growth rate of 38.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 290.60M | 137.35% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 979.93M |
| Eupraxia Pharmaceuticals | 594.48M |
| Helix BioPharma | 109.98M |
| ME Therapeutics Holdings | 75.12M |
| Eastwood Bio-Medical Canada | 67.51M |
| MedMira | 45.61M |
| NurExone Biologic | 45.60M |
| BriaCell Therapeutics | 45.41M |